Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

56460 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-11-01

Study Completion Date

2029-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Ten year safety study examining rates of rare adverse events, child bearing issues, effects of mammography, MRI compliance and results, and long-term benefit of silicone-filled breast implants.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Safety and Effectiveness of Style 410 Silicone-Filled Breast Implant Study

NCT00690339

Breast Augmentation Breast Reconstruction Revision of Augmentation or Reconstruction

COMPLETED NA

Adjunct Study of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants

NCT00691327

Breast Reconstruction

COMPLETED NA

Study of Health Effects of Cosmetic Breast Augmentation

NCT00342953

Brain Cancer Breast Cancer Lung Cancer +1 more

COMPLETED

Core Study of the Safety and Effectiveness of IDEAL IMPLANT(R) Saline-filled Breast Implants

NCT00858052

Breast Implants

COMPLETED NA

An Analysis of Adverse Events and Satisfaction Outcomes of Women Who Underwent Primary and Secondary Breast Augmentation Using Silimed® Breast Implants

NCT03356132

Breast Implant; Complications Quality of Life Satisfaction

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Implant

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NBIR - US National Breast Implant Registry

NBIR is intended to be a surveillance tool to track patient safety and real-world outcomes associated with breast implants used for aesthetic or reconstructive purposes..

Intervention Type OTHER

410 Arm

Anatomically shaped silicone gel-filled breast implants.

Intervention Type DEVICE

BIFs - Breast Implant Follow-Up Study

Round silicone gel-filled breast implants and saline-filled breast implants

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Screening Criteria

1. Female

1. age 18 years or older who is a candidate for breast reconstruction (primary or revision) with Allergan silicone implants or saline breast implants (controls) OR
2. age 22 or older who is a candidate for breast augmentation (primary or revision) with Allergan silicone implants or saline breast implants (controls)
2. Exhibit fluency and literacy in English or Spanish

Enrollment Criteria

Exclusion Criteria

2. Have completed the implant surgery
3. Have only one breast implant or have matching breast implants (i.e., both Round Responsive, both Style 410, or both saline) following their qualifying surgery. In the case of silicone, the device(s) must be manufactured by Allergan.
4. Are free of all target diseases at baseline (410 arm only)
5. Have signed the informed consent form, documenting agreement to participate in all required follow-up interviews by internet, phone, or mail and authorizing health care providers to release medical records to study personnel, and have completed the baseline questionnaire prior to implant surgery (prospectively enrolled subjects)

For retrospectively enrolled subjects into the 410 arm, in addition to the above, these criteria also apply:

1. Received 1 or 2 Style 410 implants between 2015 and 2019
2. Willing to complete baseline questionnaire at time of enrollment

Continuation Criteria (BIFS Arm Only)

1. Have completed baseline and years 1, 2, 3 and 4 follow-up questionnaires available (including the Satisfaction with Breasts and Psychosocial Well-Being modules of the BREAST-Q)
2. Met all enrollment criteria, specifically the minimum age requirements for silicone implants (18 or older for reconstruction subjects and 22 or older for augmentation subjects), and were free of all target diseases at baseline
3. Were enrolled at a site that was selected in the cluster sampling to continue in the BIFS arm

1. Are transgender
2. If a saline implant subject, have a current or past unilateral or bilateral silicone gelfilled breast implant
3. Investigator decision that subject is not a suitable candidate for a long-term observational study

Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No